Axovant Announces Dosing of First Patient... - Cure Parkinson's
Axovant Announces Dosing of First Patient in Second Cohort of SUNRISE-PD Phase 2 Trial of AXO-Lenti-PD
Written by
Farooqji
To view profiles and participate in discussions please or .
1 Reply
•
Thanks for posting this link. I've been following the progress of AXO-Lenti-PD, its early days but I think this has the potential to be an interesting development.
Not what you're looking for?
You may also like...
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s...
Phase 2 trial of Nilotinib
https://parkinsonsnewstoday.com/2018/08/24/phase-2-trial-shows-nilotinib-potential-to-modulate-dopam
BioVie announces treatment of 1st patient in Phase 2 clinical trial of NE3107,ERK inhibitor that selectively inhibits neuroinflammation
BioVie announces treatment of 1st patient in Phase 2 clinical trial of NE3107 (an ERK inhibitor...
Starting phase 2 trial : Terazosin for Parkinson's Disease (TZ-PD)
Things are moving fast. A Phase II clinical trial for Terazosin in Parkinsons is already being...
Encouraging results from the phase-I trial! The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in PD
Highlights
• Oral NR increases brain NAD levels in individuals with Parkinson’s disease
• NR...
Related Posts
ANYONE IN THIS TRIAL: Prothena PASADENA Phase 2 trial? Love to hear what you think - some say most promising PD trial.
Oral ANVS401 Improves Patients’ Motor Skills in Phase 2 Trial- ANNOVIS BIO ANNOUNCES POSITIVE FDA NOTICE FOR BUNTANETAP PHASE 3 CLINICAL TRIAL IN PARKINSON'S DISEASE
- Ambroxol in Parkinson's: Results of Phase ll Trial Published
Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease
